PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Psyllium reduces LDL cholesterol and may complement cardiovascular disease treatment [PMID:30000405]. It is effective in lowering total and LDL cholesterol by 4-8% and 6-13%, respectively [PMID:7663036].
Psyllium is a proven treatment for chronic constipation [PMID:34074830] and is considered a gold standard for regulating bowel movements, showing higher efficacy than sodium docusate or loperamide [PMID:40620304].
Psyllium facilitates weight loss in overweight and obese participants [PMID:37163454].
Psyllium has a significant effect on glycemic control in patients with type-2 diabetes and metabolic syndrome [PMID:37163454].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 37078654 (2023) — Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. · Gut microbes
- 2.PMID: 32951436 (2022) — Psyllium: a useful functional ingredient in food systems. · Critical reviews in food science and nutrition
- 3.PMID: 30000405 (2006) — Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. · The American journal of clinical nutrition
- 4.PMID: 30669509 (2019) — The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. · International journal of molecular sciences
- 5.PMID: 37163454